The impact of dry eye disease treatment on patient satisfaction and quality of life: A review

Nenhuma Miniatura disponível
Citações na Scopus
74
Tipo de produção
article
Data de publicação
2019
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE BV
Autores
GOMES, Jose A. P.
Citação
OCULAR SURFACE, v.17, n.1, p.9-19, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Several aspects of the quality of life (QoL) and treatment satisfaction of patients with dry eye disease (DED) may be underestimated. Ocular symptoms, which are assessed by validated patient-reported questionnaires and may include stinging, burning, itchiness, grittiness, dryness and discomfort, reduce QoL by affecting daily activities and work productivity. Self-reported symptoms do not always correlate with post-treatment improvements in clinical measures such as tear film break-up time, inflammation and osmolarity. Thus, treatments may improve clinical ocular features without improving symptoms that affect daily life. This review explores 1500 abstracts from congress presentations and peer-reviewed journals for QoL and treatment satisfaction data on the use of active lubricants, osmoprotectants, secretagogues, and immunomodulators present in topical formulations for DED treatment, and validated symptom questionnaires. Patient-reported symptoms of DED are generally improved after treatment with topical formulations for tear replacement, tear stimulation or anti-inflammatory therapy compared with baseline or a control treatment. However, more data are required to compare the performance of active ingredients. It is fundamental to diagnose patients with DED accurately, recognising the major cause behind their dry eyes. Studies are also necessary to identify how patient satisfaction and QoL may be improved through long-term use of topical preparations. We conclude that careful and thorough consideration of patient-reported symptoms should be integrated into DED management to help tailor treatment to patient needs.
Palavras-chave
Dry eye disease, Patient satisfaction, Quality of life, Patient-reported, Artificial tears
URI
https://observatorio.fm.usp.br/handle/OPI/30944
Referências
  1. Abetz L, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-111
  2. Amparo F, 2015, OPHTHALMOLOGY, V122, P1498, DOI 10.1016/j.ophtha.2015.02.037
  3. Barabino S, 2016, OCUL SURF, V14, P365, DOI 10.1016/j.jtos.2016.04.005
  4. Bartlett JD, 2015, CLIN OPHTHALMOL, V9, P1719, DOI 10.2147/OPTH.S89700
  5. Baudouin C, 2016, 8 INT C TEAR FILM OC
  6. Baudouin C, 2013, OCUL SURF, V11, P246, DOI 10.1016/j.jtos.2013.07.003
  7. Baudouin C, 2012, EUR J OPHTHALMOL, V22, P751, DOI [10.5301/ejo.5000181, 10.5301/ejo.5000117]
  8. Begley CG, 2003, INVEST OPHTH VIS SCI, V44, P4753, DOI 10.1167/iovs.03-0270
  9. Begley CG, 2000, OPTOMETRY VISION SCI, V77, P40, DOI 10.1097/00006324-200001000-00012
  10. Benelli U, 2011, CLIN OPHTHALMOL, V5, P783, DOI 10.2147/OPTH.S13773
  11. BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160
  12. Pinto-Bonilla JC, 2015, THER CLIN RISK MANAG, V11, P595, DOI 10.2147/TCRM.S77091
  13. Chalmers RL, 2005, CORNEA, V24, P804, DOI 10.1097/01.ico.0000154410.99691.3c
  14. Chalmers RL, 2012, OPTOMETRY VISION SCI, V89, P1435, DOI 10.1097/OPX.0b013e318269c90d
  15. Chalmers RL, 2010, CONTACT LENS ANTERIO, V33, P55, DOI 10.1016/j.clae.2009.12.010
  16. Chiambaretta F, 2017, EUR J OPHTHALMOL, V27, P1, DOI 10.5301/ejo.5000836
  17. Cohen ST, 2014, CLIN OPHTHALMOL, V8, P157, DOI 10.2147/OPTH.S53822
  18. Craig JP, 2017, OCUL SURF, V15, P276, DOI 10.1016/j.jtos.2017.05.008
  19. Davitt WF, 2010, J OCUL PHARMACOL TH, V26, P347, DOI 10.1089/jop.2010.0025
  20. Deschamps N, 2013, AM J OPHTHALMOL, V156, P184, DOI 10.1016/j.ajo.2013.02.019
  21. Fairchild CJ, 2008, OPTOMETRY VISION SCI, V85, P699, DOI 10.1097/OPX.0b013e3181824e0d
  22. FDA Ctr Drug Evaluation Res, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-79
  23. Friedman NJ, 2010, CURR OPIN OPHTHALMOL, V21, P310, DOI 10.1097/ICU.0b013e32833a8c15
  24. Grubbs JR, 2014, CORNEA, V33, P215, DOI 10.1097/ICO.0000000000000038
  25. Guillemin I, 2012, OCUL SURF, V10, P84, DOI 10.1016/j.jtos.2012.01.007
  26. Hartstein I, 2005, CURR MED RES OPIN, V21, P255, DOI 10.1185/030079905X26252
  27. Holland EJ, 2016, CURR MED RES OPIN, V32, P1759, DOI 10.1080/03007995.2016.1210107
  28. Hua X, 2015, CURR EYE RES, V40, P657, DOI 10.3109/02713683.2014.957776
  29. Igarashi T, 2015, J NIPPON MED SCH, V82, P229, DOI 10.1272/jnms.82.229
  30. International Dry Eye Workshop, 2007, OCUL SURF, V5, P61
  31. Johnson ME, 2007, INVEST OPHTH VIS SCI, V48, P4451, DOI 10.1167/iovs.06-1253
  32. Jones L, 2017, OCUL SURF, V15, P575, DOI 10.1016/j.jtos.2017.05.006
  33. Kaercher T, 2009, CLIN OPHTHALMOL, V3, P33
  34. Kawashima M, 2016, CLIN OPHTHALMOL, V10, P1015, DOI 10.2147/OPTH.S99620
  35. Kiran MM, 2017, J MED SCI CLIN RES, V5, P18316
  36. Korb DR, 2005, OPTOMETRY VISION SCI, V82, P594, DOI 10.1097/01.opx.0000171818.01353.8c
  37. Kymionis GD, 2008, CLIN OPHTHALMOL, V2, P829
  38. Labetoulle M, 2017, EYE, V31, P1409, DOI 10.1038/eye.2017.73
  39. Labetoulle M, 2017, BRIT J OPHTHALMOL, V101, P487, DOI 10.1136/bjophthalmol-2016-308608
  40. Lemp MA, 2012, CORNEA, V31, P472, DOI 10.1097/ICO.0b013e318225415a
  41. Liu KC, 2014, CURR ALLERGY ASTHM R, V14, P1
  42. Lu P, 2008, CORNEA, V27, P545, DOI 10.1097/ICO.0b013e318165b1b7
  43. Malet F, 2014, ACTA OPHTHALMOL, V92, pE429, DOI 10.1111/aos.12174
  44. Mangione CM, 1998, ARCH OPHTHALMOL-CHIC, V116, P1496, DOI 10.1001/archopht.116.11.1496
  45. Mannis MJH, 2016, CORNEA E BOOK, P387
  46. McDonald CC, 2002, EYE, V16, P601, DOI 10.1038/sj.eye.6700169
  47. McDonald M, 2016, OCUL SURF, V14, P144, DOI 10.1016/j.jtos.2015.11.002
  48. McMonnies C W, 1986, J Am Optom Assoc, V57, P512
  49. Mencucci R, 2015, J CATARACT REFR SURG, V41, P1699, DOI 10.1016/j.jcrs.2014.12.056
  50. Mertzanis P, 2005, INVEST OPHTH VIS SCI, V46, P46, DOI 10.1167/iovs.03-0915
  51. Miljanovic B, 2007, AM J OPHTHALMOL, V143, P409, DOI 10.1016/j.ajo.2006.11.060
  52. Moscovici BK, 2012, CORNEA, V31, P945, DOI 10.1097/ICO.0b013e31823f8c9b
  53. Moscovici BK, 2015, CONTACT LENS ANTERIO, V38, P373, DOI 10.1016/j.clae.2015.04.004
  54. Moss SE, 2000, ARCH OPHTHALMOL-CHIC, V118, P1264
  55. Ngo W, 2013, CORNEA, V32, P1204, DOI 10.1097/ICO.0b013e318294b0c0
  56. Nichols JJ, 2002, CORNEA, V21, P469, DOI 10.1097/01.ICO.000016340.19018.C6
  57. Nichols KK, 2006, OCUL SURF, V4, P137, DOI 10.1016/S1542-0124(12)70040-X
  58. Nichols KK, 2016, INVEST OPHTH VIS SCI, V57, P2975, DOI 10.1167/iovs.16-19419
  59. Nichols KK, 2004, CORNEA, V23, P762, DOI 10.1097/01.ico.0000133997.07144.9e
  60. Nichols KK, 2004, CORNEA, V23, P365, DOI 10.1097/00003226-200405000-00010
  61. Patel VD, 2011, CURR MED RES OPIN, V27, P1041, DOI 10.1185/03007995.2011.566264
  62. Paulsen AJ, 2014, AM J OPHTHALMOL, V157, P799, DOI 10.1016/j.ajo.2013.12.023
  63. Perez-Balbuena AL, 2016, BMC OPHTHALMOL, V16, DOI 10.1186/s12886-016-0343-9
  64. Pinto-Fraga J, 2017, EYE CONTACT LENS, V43, P57, DOI 10.1097/ICL.0000000000000236
  65. Prabhasawat P, 2007, BRIT J OPHTHALMOL, V91, P47, DOI 10.1136/bjo.2006.097691
  66. Rajagopalan K, 2005, VALUE HEALTH, V8, P168, DOI 10.1111/j.1524-4733.2005.03074.x
  67. Rolando M, 2009, J OCUL PHARMACOL TH, V25, P271, DOI 10.1089/jop.2008.0026
  68. Saeed N, 2013, PAK J MED SCI, V29, P1055, DOI 10.12669/pjms.294.3487
  69. Sakane Y, 2013, JAMA OPHTHALMOL, V131, P1331, DOI 10.1001/jamaophthalmol.2013.4503
  70. Sall K, 2000, OPHTHALMOLOGY, V107, P631, DOI 10.1016/S0161-6420(99)00176-1
  71. Sanchez MA, 2010, EYE, V24, P1331, DOI 10.1038/eye.2010.24
  72. Santo RM, 2015, J CLIN EPIDEMIOL, V68, P370, DOI 10.1016/j.jclinepi.2014.07.009
  73. Schaumberg DA, 2001, JAMA-J AM MED ASSOC, V286, P2114, DOI 10.1001/jama.286.17.2114
  74. Schaumberg DA, 2007, OCUL SURF, V5, P50, DOI 10.1016/S1542-0124(12)70053-8
  75. Schaumberg DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076121
  76. Schiffman RM, 2000, ARCH OPHTHALMOL-CHIC, V118, P615
  77. Sharma A, 2014, J OPHTHALMOL, DOI 10.1155/2014/781683
  78. Sheppard JD, 2014, OPHTHALMOLOGY, V121, P475, DOI 10.1016/j.ophtha.2013.09.015
  79. Shimazaki J, 2016, ANN M ASS RES VIS OP
  80. Simmons PA, 2007, CORNEA, V26, P294, DOI 10.1097/ICO.0b013e31802e1e04
  81. Simmons PA, 2015, CLIN THER, V37, P858, DOI 10.1016/j.clinthera.2015.01.001
  82. Solomon A, 1998, J OCUL PHARMACOL TH, V14, P497, DOI 10.1089/jop.1998.14.497
  83. Stapleton F, 2017, OCUL SURF, V15, P334, DOI 10.1016/j.jtos.2017.05.003
  84. Stevenson D, 2000, OPHTHALMOLOGY, V107, P967, DOI 10.1016/S0161-6420(00)00035-X
  85. Sullivan LJ, 1997, OPHTHALMOLOGY, V104, P1402, DOI 10.1016/S0161-6420(97)30124-9
  86. Sy A, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0122-z
  87. Takamura E, 2012, BRIT J OPHTHALMOL, V96, P1310, DOI 10.1136/bjophthalmol-2011-301448
  88. Toda I, 1996, CORNEA, V15, P120, DOI 10.1097/00003226-199603000-00003
  89. Tongg L, 2009, OPHTHAL EPIDEMIOL, V16, P31, DOI 10.1080/09286580802521317
  90. Uchino Miki, 2013, Curr Ophthalmol Rep, V1, P51
  91. Uchino M, 2014, AM J OPHTHALMOL, V157, P294, DOI 10.1016/j.ajo.2013.10.014
  92. Valim V, 2015, CLIN REV ALLERG IMMU, V49, P288, DOI 10.1007/s12016-014-8438-7
  93. Vehof J, 2013, JAMA OPHTHALMOL, V131, P1304, DOI 10.1001/jamaophthalmol.2013.4399
  94. Viso E, 2009, OPHTHAL EPIDEMIOL, V16, P15, DOI 10.1080/09286580802228509
  95. Wolffsohn JS, 2017, OCUL SURF, V15, P539, DOI 10.1016/j.jtos.2017.05.001
  96. Yamada M, 2012, CLINICOECONOMIC OUTC, V4, P307, DOI 10.2147/CEOR.S36352
  97. Yang JM, 2015, OPTOMETRY VISION SCI, V92, pE296, DOI 10.1097/OPX.0000000000000657

Coleções
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/33